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Abstract. Forty-fourSchistosomamansoni egg-negative/circulating cathodic antigen (CCA) low-positive (trace or 1+)
children in three districts of very low prevalence in Egypt were given three sequential praziquantel (PZQ) treatments. Stool
and urine specimens were collected 3 months following the initial treatment, and 3 weeks following the second and
following the third PZQ treatments, whichwere conducted 5weeks apart. Stool specimens were examined by Kato–Katz
(four slides/stool sample) and all S. mansoni egg-negative stools were further tested by the “miracidia hatching test”
(MHT). Urine samples were examined by the point-of-care CCA assay (POC-CCA). Over the study period, all stool
samples from study subjects remained S. mansoni egg negative and MHT negative. Of the POC-CCA test results, in the
first day of the study 3months following the initial treatment, 29.5%were negative, 61.4%CCA trace positives, and 9.1%
CCA 1+ positives. Following each PZQ treatment, the test results fluctuated between 1+, trace, and negative, but did not
consistently decrease. The proportions of POC-CCA–positive results obtained in the first day (70.5%) as compared with
the last day of the study (72.7%) in all of the three districts were very similar.We conclude that CCA trace and 1+ readings,
in Kato–Katz S. mansoni egg-negative children in this area with very low levels of intestinal schistosomiasis, are not
consistently altered or rendered consistently negative following repeated PZQ treatments and are therefore likely to
represent false-positive readings. This finding is of critical importance for countries such as Egypt as they approach
elimination.
INTRODUCTION
Schistosomiasis (also known as bilharzia) is a waterborne
parasitic disease endemic in 78 tropical and subtropical
countries worldwide. The disease is caused by an infection
with blood flukes of Schistosoma spp. and is transmitted to
humans through transcutaneous penetration by its larval
stages followinghumandirect contactwith infestedwater.1By
2016, it was estimated that at least 206.4 million people re-
quired preventive treatment for schistosomiasis.2 Successful
schistosomiasis control programs in Japan, China, Brazil, and
Egypt have shown that progression toward elimination of
schistosomiasis through persistent control is feasible.3 In
some areas, the global emphasis is now shifting from control
to elimination of schistosomiasis.4
Successful schistosomiasis control programs, based on
preventive chemotherapy using praziquantel (PZQ),5 have
significantly decreased disease endemicity. Consequently, to
overcome the drawbacks of the Kato–Katz stool examination
in the diagnosis of Schistosoma mansoni infection, especially
in low endemicity areas,6 several programs have used a
commercial point-of-care circulating cathodic antigen (POC-
CCA) test. Several studies conducted in low prevalence areas
have observed POC-CCA–positive persons who are S. man-
soni egg negative by the Kato–Katz assay.7–9 Because this
group (Kato–Katz–negative/POC-CCA–positive individuals)
represents a challenge for programs shifting from control to
elimination (interruption of transmission), we carried out an
in-depth study of this particular group.10 In that study, we
followed a cohort of 45 schoolchildren residing in a very low
S. mansoni prevalence area for 30 successive days. Over the
30 days, only 0.07% of stool samples were S. mansoni egg
and “miracidia hatching test” (MHT) positive. However, most
of urine POC-CCA assays (89.1%) remained positive at the
trace or 1+ level. These findings indicate that these children
are not likely to be a threat to themselves in terms of ongoing
egg-focused morbidity or to continued transmission. How-
ever, the trace and 1+ POC-CCA results, which may or may
not be false positives, were a cause for further study. It could
be hypothesized that these are not false positives and that
additional treatment with PZQwould lead to their changing to
negatives. In this case, the low-level POC-CCA readings
would indicate that these children still harbored a few viable
adult worms, perhaps secreting low levels of CCA antigens.
In the present report, we address this hypothesis by ques-
tioning whether the trace and 1+ CCA readings would change
to negative following repeated standard PZQ treatments. We
have now followed a cohort of 44 schoolchildren (of the 45
previously studied) through three rounds of PZQ treatments
by assaying their stools and urines for three successive days
following each of the three PZQ treatments.
MATERIALS AND METHODS
Ethics statement. The Ethics Review Committee of the
Ministry of Health and Population reviewed and approved the
study protocol (number 9-2018/4). The Institutional Review
Board of the University of Georgia (UGA) evaluated the pro-
tocol and determined UGA personnel to be not engaged. The
children were enrolled in the study after obtaining written in-
formed consent from their parents/guardians. The study ob-
jectives, the need for treatment, and follow-up of stool and
urine samples were explained to the children and their
parents/guardians. The work included only noninvasive col-
lections of stool and urine specimens, and standard treatment
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with PZQ. Provision of stool and urine samples was taken as
children’s assent.
Study design and subjects. The study design is shown in
Figure 1. The studywas conducted in January/February, May,
June, and July 2018 and included a cohort of 44 school-
children attending schools in three districts (Al Riad, Desouk,
andSidySalemdistricts) in Kafr El SheikhGovernorate, Egypt.
The 44 schoolchildren participated in a previous 30-day
follow-up study by our group10 and were treated with a single
regimen of PZQ (40 mg/kg) after completion of that study,
during mass treatment of their schools, conducted during
January–February 2018. Three months later in May 2018,
stool and urine samples were collected from these 44
schoolchildren on three successive days and examined. Each
stool sample was examined by Kato–Katz (four slides/stool
sample), and all S. mansoni egg-negative samples by Kato–
Katz were also examined by the MHT. Each urine sample was
assayed by the POC-CCA (one urine/one POC-CCA). Each of
the 44 schoolchildren were then treated a second time (May
2018) and a third time (June 2018), each timewith 40mg/kg of
PZQ. Three weeks after each of these treatments, each of the
44 schoolchildren had stool and urine samples collected on
three successive days in June and July, respectively, and
assayed in the same way by Kato–Katz and POC-CCA.
Kato–Katz thick smear technique. The Kato–Katz stool
analysis was performed according to the WHO standard
procedure.11
Point-of-care circulating cathodic antigen assay. The
POC-CCA test (batch number: 170914118; expiration date:
9/2019) was performed according to the manufacturer’s in-
struction (Rapid Medical Diagnostics, Pretoria, South Africa).
Briefly, two drops of urinewere added to the samplewell of the
cassette and allowed to absorb completely into the specimen
pad. The testwas read after 20minutes; any line in the test area
was considered positive, and the band density was recorded.
In reading and scoring the POC-CCA results, we used 10
(G1–G10) “standardized POC-CCA cassettes” graded G1
(negative test) to G10 (strong positive). The relationship be-
tween the G1–G10 grading scale and the more standard
evaluations of negative, trace, 1+, 2+, and 3+ was described
previously.10 Briefly, G1 indicates no observable CCA band;
that is, a negativePOC-CCA; band intensities ofG2 andG3are
considered trace readings,whereas band intensities of G4 and
G5 are considered 1+ readings. The test was considered in-
valid if the line developed after 25 minutes or no control line
developed. The test was read and agreed on by two observers
(laboratory assistant or laboratory technician), and in case of
disagreement, resultswerediscussedand resolvedbya senior
laboratory technician.
The MHT. This technique was performed as previously
described.12 Briefly, from each stool sample, a portion of
about 3 gmwasemulsified in 75mLof physiological saline and
sieved rapidly through five successive standard brass sieves
(meshopenings2,000, 500, 212, 125, and32μm, respectively)
by spraying dechlorinated water from a 2-L plastic spray
bottle. Anymaterial remaining on the upper surface of the last,
smallest,mesh-opening sievewaswashedwith dechlorinated
water into a 1-L clear conical flask, which was covered com-
pletely with a black cloth except the small neck, and filled with
dechlorinated water (pH 7.4–7.6) to the rim. The flask was left
strongly illuminated from one side at room temperature. After
2, 4, and 6 hours, each flask rim was examined for swimming
miracidia using a handheld lens. Observedmiracidia indicated
a positive MHT, that is, presence of viable S. mansoni eggs in
the stool sample. The absence of miracidia indicated a neg-
ative MHT, that is, no viable, mature S. mansoni eggs in the
stool sample assayed.
Statistical analyses. Data entry was performed on Micro-
soft Excel database spreadsheet and the descriptive data are
presented. Although three stool and three urine specimens
were obtained on three consecutive days at each parasito-
logic survey time point in this research study, we herein report
most of the data based on the assays performed on the first
day’s specimens at each time point. This emphasis on the first
day’s specimens is because most neglected tropical disease
programs would likely only collect one specimen for pro-
grammatic surveys.
RESULTS
Praziquantel treatments. A total of 44 schoolchildren (14
from Al Riad, and 15 each from Desouk and Sidy Salem dis-
trict, Kafr El Sheikh Governorate) were enrolled in this study
and received three successive treatmentswith PZQ (Figure 1).
The cohort comprised 17 males and 27 females and they
ranged from 8 to 15 years of age (mean age: 11.1 ± 1.6 years).
All study children were directly observed to have ingested the
drug tablets at each treatment, and they reported that theyhad
had no activity in or contact with fresh water possibly infested
with schistosome larvae starting in January 2018 (because of
cold weather) and during the period of the study.
Parasitological examination. The study included three
follow-up parasitological evaluations, and at each follow-up
evaluation time point, a stool sample was collected on each of
FIGURE 1. Flow diagram of the follow-up protocol following three
rounds of PZQ treatment. At each survey time point, three stool and
three urine samples were collected on consecutive days and were
examined by Kato–Katz and POC-CCA assay, respectively. POC-
CCA=point-of-care circulating cathodic antigen; PZQ=praziquantel.
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three successive days (Figure 1). Throughout the study, all
Kato–Katz examinations and all MHT assays were uniformly
negative from all of the schoolchildren.
Point-of-care circulating cathodic antigen testing. As
with the parasitological testing, at each of the three follow-up
survey times, a urine specimen was collected on each of the
three successive days and eachurine specimenwas tested by
a POC-CCA assay (Figure 1). As shown in Table 1, the POC-
CCA test results of the first day of the follow-up evaluation
3 months after the initial treatment were 13 (29.5%) CCA
negatives, 27 (61.4%) CCA trace positives, and four (9.1%)
CCA 1+ positives. The number of POC-CCA positives (31
[70.45%]) recorded on the first day of the initial evaluation
following the first treatment was very similar to that recorded
on the first day of the last evaluation (32 [72.7%]), following the
last of the three treatments. Thus, overall, there was no dif-
ference between themixture of POC-CCA results recorded on
the first day of the study for the three districts as compared
with the last day of the study, following three PZQ treatments:
12 (27.3%) CCA negatives, 26 (59.1%) CCA trace, and six
(13.6%) CCA 1+. Table 1 compares these POC-CCA results
recorded for the first and last daysof thestudy for eachdistrict.
Figures 2–4 compare the POC-CCA results of the first day of
each follow-up for each child in Desouk, Al Riad, and Sidy
Salem districts, respectively, following each of the three PZQ
treatments. The POC-CCA test results fluctuated irregularly
between being 1+, trace, and negative.
It can be seen in Figures 2–4 that there were several nega-
tive POC-CCA readings for the first urine evaluations at the
last time points. Figures 2–4 graph data from the first of three
urines at each of the three posttreatment surveys. By this
presentation, there is only one child (representing 2.3% of the
group of 44) who was actually CCA negative for all three urine
specimens after the second and third PZQ treatments. How-
ever, when evaluating all three urine POC-CCA readings
obtained at the time of the last survey, there were three chil-
dren (6.8%) who had negative CCA readings for all three of
their last urine specimens. Nevertheless, none of the test re-
sults of the other 41 children (93.2%) consistently became
negative following multiple PZQ treatments. Based on the
continued variation we observed across the three urines from
these 41 children at the final survey, the several negatives on
the first urines appear to represent the consistently observed
variation from 1+ to trace to negative.
DISCUSSION
This study was designed to answer an important question
related to the specificity of the POC-CCA assay in very low
prevalence of S. mansoni–endemic areas. This is particularly
important if the CCA urine assay is to be used to guide in-
tervention choices as overall prevalence declines and elimi-
nationofS.mansoni transmissionappears feasible. If the trace
and 1+ CCA readings we reported previously10 were because
of viable adult worms present in the study children secreting
low levels of CCA antigens, such readings would be expected
to have changed to consistently negative following repeated
treatments with standard doses of PZQ.
Our finding that there was no difference in the ratio of POC-
CCA–positive results in the study children on the first day of
the study (3 months after an initial treatment with PZQ) com-
pared with the last day of the study (after these three cycles of
PZQ treatment), (70.45%versus 72.7%), clearly indicates that
the trace and 1+ CCA readings are very unlikely to be due to
viable S. mansoni worms. Accordingly, the specificity of the
trace CCA bands observed for these Kato–Katz–negative
children is more likely lower than those observed in higher
prevalence S. mansoni–endemic settings.
In a previous study carried out by Mwinzi et al.,7 one or two
PZQ treatments converted most Kato–Katz–negative/POC-
CCA–positive individuals to POC-CCA negativity. School-
children enrolled in their study were from an area of 10–15%
TABLE 1
Comparison of the first POC-CCA readings recorded for the 44
schoolchildren 3 months following the first treatment (first day) and
3 weeks following the third treatment (last day) of the study pre-
sented by district
District Day of study
POC-CCA scores
G1 (negative) G2–G3 (trace) G4–G5 (1+)
No. (%) No. (%) No. (%)
Desouk (n = 15) First day 2 (13.3) 11 (73.4) 2 (13.3)
Last day 4 (26.7) 7 (46.6) 4 (26.7)
Al Riad (n = 14) First day 4 (28.6) 9 (64.3) 1 (7.1)
Last day 3 (21.4) 10 (71.5) 1 (7.1)
Sidy Salem (n = 15) First day 7 (46.7) 7 (46.7) 1 (6.7)
Last day 5 (33.3) 9 (60.0) 1 (6.7)
All districts (n = 44) First day 13 (29.5) 27 (61.4) 4 (9.1)
Last day 12 (27.3) 26 (59.1) 6 (13.6)
POC-CCA = point-of-care circulating cathodic antigen.
G1 indicates no observable CCA band, that is, a negative POC-CCA.
G2 and G3 band intensities are considered trace readings.
G4 and G5 band intensities are considered 1+.
FIGURE 2. Point-of-care circulating cathodic antigen results of 15
children studied in Desouk district, following three rounds of prazi-
quantel treatment. Urines were collected from 15 children 3 months
after their initial treatment with PZQ and assayed by POC-CCA (black
bars). They were then treated a second time with PZQ, and 3 weeks
later, their urines were collected and assayed by POC-CCA (open
bars). Theywere then treated a third timewith PZQ, and 3weeks later,
their urines were collected and assayed by POC-CCA (hatched bars).
The numbers on the Y axis denote the band intensity readings on the
G1 to G10 scale. The horizontal black line is at a reading of one, which
indicates no observable CCA band, therefore a negative POC-CCA.
The horizontal dashed line is set to mark the limit of trace readings
(band intensities of two and three), greater thanwhich are considered
1+ readings (band intensities of four and five). At each time point, urines
werecollectedandassayedon three consecutive days, butonly the first
day’s results are plotted in this graph. POC-CCA = point-of-care
circulating cathodic antigen; PZQ = praziquantel.
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prevalenceby theKato–Katzmethod.Note that according to a
report by theWHO,13 an areawith a prevalence less than 10%
and an intensity of infection < 100 eggs per gram of feces
should be considered a low endemic zone. In our study,
however, the 44 schoolchildren were selected from three
districts, Desouk, Al Riad, and Sidy Salem, where the overall
prevalence of S. mansoni infection, as determined by the
Kato–Katz stool examination,8 was very low (1.2%, 0%, and
0.9%, respectively).10 Thus, the findings of our study add
significant new information of particular programmatic in-
terest in such very low prevalence areas.
Wedid see that three children had negativeCCA readings for
all threeof their last threeurinespecimens.Although thegeneral
inconsistency of the CCA readings of negative, trace, and 1+
might argue against firm conclusions regarding these three
children, it is certainly possible that one or more of these chil-
dren (6.8% of those studied) had a few worms that were
eventually killed by themultiple treatments. However, given the
repeated fluctuations of urine readings between negative and
1+bymost children (93.2%), it is just as likely that conversion to
negative by these three children was due to chance readings.
To the best of our knowledge, no previous formal study has
addressed the performance of the POC-CCA assay in such a
very low S. mansoni–endemic setting, following years of per-
sistent programmatic control measures.8 Additional studies in
other areas of very low prevalence and intensity of S. mansoni
infection shouldbeencouraged. In addition, newsensitive and
specific diagnostic tools, such as the up-converting phosphor
lateral flow circulating anodic antigen assay, possibly through
specimen pooling strategies,14 will be needed as more
country programs move from control to elimination (in-
terruption of transmission) of S. mansoni.
In conclusion, the present findings support our previous
proposition that children who are Kato–Katz negative/POC-
CCA trace or 1+, and reside in areaswith such lowprevalence,
are not likely to be a threat to themselves, nor are they likely to
contribute to substantial continued transmission.10 Further-
more, the variability and lack of turning consistently negative
after multiple treatments make it likely that the trace and 1+
CCA readings in such areas are false positives.
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FIGURE 4. Point-of-care circulating cathodic antigen results of 15
children studied in Sidy Salem district, following three rounds of pra-
ziquantel treatment. Urines were collected from 15 children 3 months
after their initial treatment with PZQ and assayed by POC-CCA (black
bars). They were then treated a second time with PZQ, and 3 weeks
later, their urines were collected and assayed by POC-CCA (open
bars). They were then treated a third timewith PZQ, and 3weeks later,
their urines collected and assayed by POC-CCA (hatched bars). The
numbers on the Y axis denote the band intensity readings on theG1 to
G10 scale. The horizontal black line is at a reading of one, which
indicates no observable CCA band, therefore a negative POC-CCA.
The horizontal dashed line is set to mark the limit of trace readings
(band intensities of two and three), greater thanwhich are considered
1+ readings (band intensities of four and five). At each time point, urines
werecollectedandassayedon three consecutivedays, butonly the first
day’s results are plotted in this graph. POC-CCA = point-of-care
circulating cathodic antigen; PZQ = praziquantel.
FIGURE 3. Point-of-care circulating cathodic antigen results of 14
children studied in Al Riad district, following three rounds of prazi-
quantel treatment. Urines were collected from 15 children 3 months
after their initial treatment with PZQ and assayed by POC-CCA (black
bars). They were then treated a second time with PZQ, and 3 weeks
later, their urines were collected and assayed by POC-CCA (open
bars). Theywere then treated a third timewith PZQ, and 3weeks later,
their urines collected and assayed by POC-CCA (hatched bars). The
numbers on theY axis denote the band intensity readings on theG1 to
G10 scale. The horizontal black line is at a reading of one, which
indicates no observable CCA band, therefore a negative POC-CCA.
The horizontal dashed line is set to mark the limit of trace readings
(band intensities of two and three), greater thanwhich are considered
1+ readings (band intensities of four and five). At each time point, urines
were collectedandassayedon threeconsecutivedays, butonly the first
day’s results are plotted in this graph. POC-CCA = point-of-care
circulating cathodic antigen; PZQ = praziquantel.
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